Histamine-2(H2 ) Antagonists can be safely removed from standard Paclitaxel Pre-medication regimens.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15363
Abstract: AIM To investigate the rates of hypersensitivity reactions (HSRs), in patients receiving paclitaxel chemotherapy, with and without a Histamine-2 (H2 ) antagonists. METHOD This prospective, multi-centre, cohort study compared patients receiving paclitaxel treated with pre-medication… read more here.
Keywords: histamine antagonists; medication regimens; paclitaxel; antagonists safely ... See more keywords